Author

S. E. Church

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Research Focus:differential expression· 1 Research Focus:spatial domain detection· 1 Approach:statistical model· 1

Frequent Co-Authors

B. Lowenberg· 2 shared H. Altmann· 2 shared J. F. DiPersio· 2 shared J. K. Davidson-Moncada· 2 shared J. Muth· 2 shared J. Vadakekolathu· 2 shared M. Bornhauser· 2 shared S. Reeder· 2 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

B. Lowenberg

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivMar 30, 2023

Spatiotemporally organized immunomodulatory response to SARS-CoV-2 virus in primary human broncho-alveolar epithelia

D. C. Castaneda, S. Jangra, M. Yurieva…·K. Palucka

This study examines the spatiotemporal immune response to SARS-CoV-2 in human broncho-alveolar epithelia, finding variant-specific kinetics and spatially organized gene expression patterns.

DOI 10.1016/j.isci.2023.107374

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintFeb 28, 2020

TP53 abnormalities correlate with immune infiltration and are associated with response to flotetuzumab, an investigational immunotherapy, in acute myeloid leukemia

C. Lai, J. Vadakekolathu, S. Reeder…·S. Rutella

This paper shows TP53 mutations in AML are linked to immune features and improved response to flotetuzumab immunotherapy.

DOI 10.1101/2020.02.28.961391

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivJul 26, 2019

Immune Landscapes Predict Chemotherapy Resistance And Immunotherapy Response In Acute Myeloid Leukemia

J. Vadakekolathu, M. D. Minden, T. Hood…·S. Rutella

This study identifies immune subtypes in AML and shows that IFN-gamma profiles predict chemotherapy resistance and immunotherapy response.

DOI 10.1126/scitranslmed.aaz0463

humanbulk RNA-seq

𝕏 PostBluesky